Investor insights
Sectors invested in
Funding rounds participated in
$42M sweet spot round size
Most of their 15 investments are in rounds between $20M and $80M
Investor type
Basic info
Date founded
1983
Investments made
Sapience Therapeutics, Inc. raised $41M on May 31, 2022
Investors: Eshelman Ventures, LLC, Bristol-Myers Squibb, UK and Kingdon Capital Management
Shoreline Biosciences, Inc. raised $140M on November 2, 2021
Investors: NS Investment, Wedbush Securities, Irving Investors, Stork Capital S.à.r.l., -, Eventide Asset Management, Piper Sandler and Kingdon Capital Management
Jasper Therapeutics raised $100M on September 27, 2021
Investors: Qiming Venture Partners USA, Avego Healthcare Capital, Velan Capital, Metalmark Capital, Woodline Partners LP, Apeiron Investment Group and Kingdon Capital Management
CeQur raised $115M on April 13, 2021
Investors: VI Partners AG, Endeavour Vision, Tandem Diabetes Care and Kingdon Capital Management
Imago BioSciences, Inc. raised $80M on November 19, 2020
Investors: Omega Funds, Greenspring Associates, Xeraya Capital, Irving Investors, Surveyor Capital, T. Rowe Price and Kingdon Capital Management
Athenex raised $60M on December 5, 2019
Investors: Kingdon Capital Management
Stealth BioTherapeutics raised $100M on June 18, 2018
Investors: Sagamore Investment Management, BioVeda China Fund and Kingdon Capital Management
SteadyMed raised $30M on April 23, 2017
Investors: Adage Capital Management, OrbiMed Advisors and Kingdon Capital Management
Undisclosed raised $2M on January 3, 2017
Investors: Kingdon Capital Management
Bill Me Later, Inc. raised $27M on March 1, 2006
Investors: Azure Capital Partners, Upfront Ventures and Kingdon Capital Management